BR9602337A - Composto processo para sua preparação usos do mesmo processo para tratamento de arritmias e medicamento - Google Patents
Composto processo para sua preparação usos do mesmo processo para tratamento de arritmias e medicamentoInfo
- Publication number
- BR9602337A BR9602337A BR9602337A BR9602337A BR9602337A BR 9602337 A BR9602337 A BR 9602337A BR 9602337 A BR9602337 A BR 9602337A BR 9602337 A BR9602337 A BR 9602337A BR 9602337 A BR9602337 A BR 9602337A
- Authority
- BR
- Brazil
- Prior art keywords
- medication
- preparation uses
- treating arrhythmias
- compound
- same process
- Prior art date
Links
- 206010003119 arrhythmia Diseases 0.000 title 1
- 230000006793 arrhythmia Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
- C07C279/10—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by doubly-bound oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
- C07C279/24—Y being a hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/16—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C317/22—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
- C07C317/46—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D215/14—Radicals substituted by oxygen atoms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19518073A DE19518073A1 (de) | 1995-05-17 | 1995-05-17 | Substituierte Benzyloxycarbonylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9602337A true BR9602337A (pt) | 1998-09-01 |
Family
ID=7762133
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9602337A BR9602337A (pt) | 1995-05-17 | 1996-05-17 | Composto processo para sua preparação usos do mesmo processo para tratamento de arritmias e medicamento |
Country Status (29)
| Country | Link |
|---|---|
| US (2) | US5753710A (pt) |
| EP (1) | EP0748795B1 (pt) |
| JP (1) | JP3962110B2 (pt) |
| KR (1) | KR960040130A (pt) |
| CN (1) | CN1062555C (pt) |
| AR (1) | AR002741A1 (pt) |
| AT (1) | ATE195726T1 (pt) |
| AU (1) | AU701567B2 (pt) |
| BR (1) | BR9602337A (pt) |
| CA (1) | CA2176796C (pt) |
| CZ (1) | CZ288332B6 (pt) |
| DE (2) | DE19518073A1 (pt) |
| DK (1) | DK0748795T3 (pt) |
| ES (1) | ES2149403T3 (pt) |
| GR (1) | GR3034573T3 (pt) |
| HR (1) | HRP960221B1 (pt) |
| HU (1) | HUP9601321A3 (pt) |
| IL (1) | IL118278A (pt) |
| MY (1) | MY115805A (pt) |
| NO (1) | NO306156B1 (pt) |
| NZ (1) | NZ286583A (pt) |
| PL (1) | PL183629B1 (pt) |
| PT (1) | PT748795E (pt) |
| RU (1) | RU2188191C2 (pt) |
| SI (1) | SI0748795T1 (pt) |
| SK (1) | SK282010B6 (pt) |
| TR (1) | TR199600400A2 (pt) |
| TW (1) | TW355705B (pt) |
| ZA (1) | ZA963893B (pt) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19960204A1 (de) * | 1999-12-14 | 2001-06-28 | Aventis Pharma Gmbh | Substituierte Norlbornylamino-Derivate, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| US6740776B2 (en) | 2001-07-16 | 2004-05-25 | Novartis Ag | Air oxidation of an aromatic aldehyde to an aromatic acid |
| AU2012227383B2 (en) | 2011-03-15 | 2016-05-19 | Astellas Pharma Inc. | Guanidine compound |
| EA201491472A1 (ru) | 2012-02-03 | 2015-01-30 | Басф Се | Фунгицидные соединения пиримидина |
| WO2013113720A1 (en) | 2012-02-03 | 2013-08-08 | Basf Se | Fungicidal pyrimidine compounds |
| WO2013113776A1 (en) | 2012-02-03 | 2013-08-08 | Basf Se | Fungicidal pyrimidine compounds |
| JP2015508752A (ja) | 2012-02-03 | 2015-03-23 | ビーエーエスエフ ソシエタス・ヨーロピアＢａｓｆ Ｓｅ | 殺菌性ピリミジン化合物 |
| WO2013113773A1 (en) | 2012-02-03 | 2013-08-08 | Basf Se | Fungicidal pyrimidine compounds |
| WO2013113787A1 (en) | 2012-02-03 | 2013-08-08 | Basf Se | Fungicidal pyrimidine compounds |
| WO2013113716A1 (en) | 2012-02-03 | 2013-08-08 | Basf Se | Fungicidal pyrimidine compounds |
| WO2013135672A1 (en) | 2012-03-13 | 2013-09-19 | Basf Se | Fungicidal pyrimidine compounds |
| JP6484220B2 (ja) * | 2014-03-28 | 2019-03-13 | 株式会社カネカ | トリ−カルボベンゾキシ−アルギニンの製造方法 |
| UA121930C2 (uk) * | 2016-05-12 | 2020-08-10 | Бьорінгер Інгельхайм Інтернаціональ Гмбх | Піридинільні похідні, фармацевтичні композиції та їх застосування як інгібіторів аос3 |
| CN109111376B (zh) * | 2018-09-18 | 2021-09-14 | 四川医立特生物医药有限公司 | 一种2,5-双脱氧链霉胺衍生物及其应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2734904A (en) * | 1956-02-14 | Xcxnhxc-nh | ||
| BE844832A (fr) * | 1976-08-03 | 1977-02-03 | Rorer Inc William H | Nouvelles amidinourees, leur preparation et leur emploi |
| GB8523606D0 (en) * | 1985-09-25 | 1985-10-30 | Shell Int Research | Pesticidal benzoylurea compounds |
| DE3929582A1 (de) * | 1989-09-06 | 1991-03-07 | Hoechst Ag | Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament |
| DE59403818D1 (de) * | 1993-02-20 | 1997-10-02 | Hoechst Ag | Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, als Inhibitoren des zellulären Na+/H+-Austauschs oder als Diagnostikum sowie sie enthaltendes Medikament |
| DE4328869A1 (de) * | 1993-08-27 | 1995-03-02 | Hoechst Ag | Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
-
1995
- 1995-05-17 DE DE19518073A patent/DE19518073A1/de not_active Withdrawn
-
1996
- 1996-05-13 AT AT96107586T patent/ATE195726T1/de not_active IP Right Cessation
- 1996-05-13 DK DK96107586T patent/DK0748795T3/da active
- 1996-05-13 ES ES96107586T patent/ES2149403T3/es not_active Expired - Lifetime
- 1996-05-13 SI SI9630255T patent/SI0748795T1/xx unknown
- 1996-05-13 DE DE59605782T patent/DE59605782D1/de not_active Expired - Lifetime
- 1996-05-13 EP EP96107586A patent/EP0748795B1/de not_active Expired - Lifetime
- 1996-05-13 PT PT96107586T patent/PT748795E/pt unknown
- 1996-05-15 AR ARP960102580A patent/AR002741A1/es not_active Application Discontinuation
- 1996-05-15 US US08/648,499 patent/US5753710A/en not_active Expired - Lifetime
- 1996-05-15 PL PL96314253A patent/PL183629B1/pl unknown
- 1996-05-15 RU RU96109706/04A patent/RU2188191C2/ru not_active IP Right Cessation
- 1996-05-15 NO NO962006A patent/NO306156B1/no not_active IP Right Cessation
- 1996-05-15 IL IL11827896A patent/IL118278A/en not_active IP Right Cessation
- 1996-05-15 CN CN96107454A patent/CN1062555C/zh not_active Expired - Fee Related
- 1996-05-15 TR TR96/00400A patent/TR199600400A2/xx unknown
- 1996-05-15 CZ CZ19961415A patent/CZ288332B6/cs not_active IP Right Cessation
- 1996-05-15 SK SK629-96A patent/SK282010B6/sk unknown
- 1996-05-15 HR HR960221A patent/HRP960221B1/xx not_active IP Right Cessation
- 1996-05-15 AU AU52294/96A patent/AU701567B2/en not_active Ceased
- 1996-05-15 NZ NZ286583A patent/NZ286583A/en unknown
- 1996-05-16 KR KR1019960016312A patent/KR960040130A/ko not_active Application Discontinuation
- 1996-05-16 ZA ZA9603893A patent/ZA963893B/xx unknown
- 1996-05-16 CA CA002176796A patent/CA2176796C/en not_active Expired - Fee Related
- 1996-05-16 HU HU9601321A patent/HUP9601321A3/hu unknown
- 1996-05-16 MY MYPI96001851A patent/MY115805A/en unknown
- 1996-05-16 JP JP12142196A patent/JP3962110B2/ja not_active Expired - Fee Related
- 1996-05-17 BR BR9602337A patent/BR9602337A/pt active Search and Examination
- 1996-06-14 TW TW085107134A patent/TW355705B/zh active
-
1998
- 1998-01-09 US US09/005,163 patent/US6022899A/en not_active Expired - Lifetime
-
2000
- 2000-10-06 GR GR20000402262T patent/GR3034573T3/el not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9408148A (pt) | Processo para tratamento de arritmia composto e formulação farmacêutica | |
| BR9600148A (pt) | Quinazolinonas 2,8-dissubstituídas processo para sua preparação medicamentos e uso | |
| BR9408463A (pt) | Novos derivados de ginkgolide e processo para sua preparação | |
| BR9601093A (pt) | Pirido(3,2-E)pirazinoas processo para sua preparação medicamentos processo para sua preparação e utilização | |
| BR1100850A (pt) | Composto, processo para a preparação de um composto, e, composição farmacêutica | |
| BR9400616A (pt) | Processo para a preparação de 1,1,1,4,4,4-hexafluorbuteno-2 | |
| ITMI921488A1 (it) | Granulati, processo per la loro preparazione e loro impiego | |
| BR9602337A (pt) | Composto processo para sua preparação usos do mesmo processo para tratamento de arritmias e medicamento | |
| BR9303456A (pt) | Compostos,processo para sua preparacao,medicamentos,processo para sua preparacao e emprego | |
| BR9301180A (pt) | Processo para a preparacao de isocianatos e emprego | |
| BR9204547A (pt) | Hidroxipiridoncarboxamidas,processo de sua preparacao e aplicacao | |
| BR9609533A (pt) | Processo para preparação de 3-hidroxipirazóis n-substituídos | |
| BR9400604A (pt) | Processo para a preparação de 1,1,1,3,3-pentafluorpropano | |
| BR9600254A (pt) | Composto processo para a sua preparação seus usos método para o tratamento de arritmias e medicamento contendo o mesmo | |
| BR9605759A (pt) | Processo contínuo para preparação de 4-mino-2,2,6,6-tetrametilpiperidina | |
| BR9302389A (pt) | Composto,formulacao farmaceutica e processo para preparar o composto | |
| BR9202446A (pt) | Composicao de dentifricio,dentifricio e processo para a preparacao de um dentifricio | |
| BR9400338A (pt) | Processo para preparação de 1,1,1,2-tetrafluoro-2-cloroetano e de pentafluoretano | |
| BR8907583A (pt) | Processo para preparacao de 2',3'-dideoxinucleosideos | |
| BR9301676A (pt) | Processo para a preparacao de 1,1,1,4,4,4-hexafluorbutano e compostos obtidos | |
| BR9401483A (pt) | Composto e processo para sua preparação | |
| BR8904468A (pt) | Composicao,processo para a preparacao de produtos e aplicacao | |
| BR9505571A (pt) | Oligômero composto medicamento processo para a produção de um medicamento e uso | |
| BR9600370A (pt) | Benzenossulfoniluréias e-tiouréias substituídas processo para a sua preparação seus usos e medicamento contendo as mesmas | |
| BR9611010A (pt) | Processo para preparação de medicamento antimalária |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB34 | Technical and formal requirements: requirement - article 34 of industrial property law | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |